RenovoRx, Inc.
RNXTNASDAQHealthcare● Active
$0.90
+$0.02(+1.91%)
Market Cap$33595562
P/E Ratio—
52W High$1.45
52W Low$0.701
RenovoRx, Inc.（RNXT）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · RNXT · 截至 Jun 9, 2026
关键指标
探索 RenovoRx, Inc. 数据
rnxt stock data · financials竞争对手与同行
rnxt competitors#TickerCompanyPriceChangeMkt Cap
#1RNXTRenovoRx, Inc.
$0.90+1.91%$33.6M#2
ANVSAnnovis Bio, Inc.
$1.79+1.40%$35.2M#3
BCABBioAtla, Inc.
$3.31-0.60%$4.2M#4
CALCCalciMedica, Inc.
$0.96-1.41%$15.1M#5
CELUCelularity Inc.
$0.81-0.24%$19.5M#6
ELUTElutia Inc.
$0.99+6.04%$43.8M关于 RenovoRx, Inc.
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative dru…
what is renovorx, inc. · rnxt stock overview · renovorx, inc. company profile · who is renovorx, inc. ceo · rnxt NASDAQ · renovorx, inc. headquarters · renovorx, inc. business segments
关于股票概览与关键数据
RenovoRx, Inc.（RNXT）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 26, 2021 在 NASDAQ 上市。截至最近交易日，RNXT 股价为 $0.90，市值约为 $33.6M。过去12个月累计回报 —，年初至今回报 —。
常见问题
截至最近一个交易日，RenovoRx, Inc.（RNXT）股价为 $0.90，在 NASDAQ 上市，52周区间为 $0.70 – $1.45。
RNXT 最新股价RNXT quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议